HHATL | Hedgehog acyltransferase-like | Predicted membrane proteins
| | | | | Group enriched |
HTR3E | 5-hydroxytryptamine (serotonin) receptor 3E, ionotropic | Predicted membrane proteins
| | | | | Not detected |
HVCN1 | Hydrogen voltage-gated channel 1 | Predicted membrane proteins Transporters
| | | | | Tissue enhanced |
JKAMP | JNK1/MAPK8-associated membrane protein | Cancer-related genes Predicted membrane proteins
| | | | | Expressed in all |
KCNK1 | Potassium channel, subfamily K, member 1 | Predicted membrane proteins Voltage-gated ion channels
| | | | | Mixed |
KCNQ1 | Potassium voltage-gated channel, KQT-like subfamily, member 1 | Disease related genes FDA approved drug targets Plasma proteins Predicted membrane proteins Transporters Voltage-gated ion channels
| | | | | Tissue enhanced |
KRTCAP3 | Keratinocyte associated protein 3 | Predicted membrane proteins
| | | | | Mixed |
MARVELD2 | MARVEL domain containing 2 | Disease related genes Predicted membrane proteins
| | | | | Tissue enhanced |
MPV17L | MPV17 mitochondrial membrane protein-like | Predicted membrane proteins
| | | | | Mixed |
MS4A2 | Membrane-spanning 4-domains, subfamily A, member 2 | FDA approved drug targets Predicted membrane proteins
| | | | | Mixed |
MS4A8 | Membrane-spanning 4-domains, subfamily A, member 8 | Predicted membrane proteins
| | | | | Group enriched |
NOX1 | NADPH oxidase 1 | Plasma proteins Predicted membrane proteins Transporters
| | | | | Group enriched |
OCLN | Occludin | Disease related genes Potential drug targets Predicted membrane proteins Predicted secreted proteins Transporters
| | | | | Mixed |
PEMT | Phosphatidylethanolamine N-methyltransferase | Enzymes Mitochondrial proteins Predicted membrane proteins
| | | | | Expressed in all |
PLLP | Plasmolipin | Predicted membrane proteins
| | | | | Mixed |
PLP1 | Proteolipid protein 1 | Cancer-related genes Disease related genes Potential drug targets Predicted membrane proteins Transporters
| | | | | Tissue enriched |
PPAPDC3 | Phosphatidic acid phosphatase type 2 domain containing 3 | Predicted membrane proteins
| | | | | Group enriched |
RHCG | Rh family, C glycoprotein | Predicted membrane proteins Transporters
| | | | | Group enriched |
RNFT2 | Ring finger protein, transmembrane 2 | Predicted membrane proteins
| | | | | Tissue enhanced |
SCAMP2 | Secretory carrier membrane protein 2 | Predicted membrane proteins
| | | | | Expressed in all |
SCAMP4 | Secretory carrier membrane protein 4 | Predicted membrane proteins
| | | | | Expressed in all |
SCAMP5 | Secretory carrier membrane protein 5 | Predicted membrane proteins
| | | | | Tissue enhanced |
SGMS1 | Sphingomyelin synthase 1 | Enzymes Plasma proteins Predicted membrane proteins
| | | | | Expressed in all |
SLC13A3 | Solute carrier family 13 (sodium-dependent dicarboxylate transporter), member 3 | Predicted membrane proteins Transporters
| | | | | Tissue enriched |
SLC1A5 | Solute carrier family 1 (neutral amino acid transporter), member 5 | Plasma proteins Predicted membrane proteins Transporters
| | | | | Expressed in all |
SLC1A6 | Solute carrier family 1 (high affinity aspartate/glutamate transporter), member 6 | Predicted membrane proteins Transporters
| | | | | Group enriched |
SLC25A22 | Solute carrier family 25 (mitochondrial carrier: glutamate), member 22 | Disease related genes Mitochondrial proteins Plasma proteins Potential drug targets Predicted membrane proteins Transporters
| | | | | Tissue enhanced |
SLC25A26 | Solute carrier family 25 (S-adenosylmethionine carrier), member 26 | Mitochondrial proteins Predicted membrane proteins Predicted secreted proteins Transporters
| | | | | Expressed in all |
SLC26A6 | Solute carrier family 26 (anion exchanger), member 6 | Plasma proteins Predicted membrane proteins Transporters
| | | | | Expressed in all |
SLC27A5 | Solute carrier family 27 (fatty acid transporter), member 5 | Enzymes Predicted membrane proteins Transporters
| | | | | Tissue enriched |
SLC28A2 | Solute carrier family 28 (concentrative nucleoside transporter), member 2 | Predicted membrane proteins Transporters
| | | | | Tissue enhanced |
SLC2A3 | Solute carrier family 2 (facilitated glucose transporter), member 3 | Predicted membrane proteins Transporters
| | | | | Expressed in all |
SLC43A1 | Solute carrier family 43 (amino acid system L transporter), member 1 | Predicted membrane proteins Transporters
| | | | | Expressed in all |
SLC4A4 | Solute carrier family 4 (sodium bicarbonate cotransporter), member 4 | Disease related genes Potential drug targets Predicted membrane proteins Transporters
| | | | | Tissue enhanced |
SLC51A | Solute carrier family 51, alpha subunit | Predicted membrane proteins Predicted secreted proteins Transporters
| | | | | Expressed in all |
SLC5A2 | Solute carrier family 5 (sodium/glucose cotransporter), member 2 | Disease related genes FDA approved drug targets Predicted membrane proteins Transporters
| | | | | Tissue enriched |
SLC8A1 | Solute carrier family 8 (sodium/calcium exchanger), member 1 | FDA approved drug targets Predicted membrane proteins Predicted secreted proteins Transporters
| | | | | Tissue enhanced |
SLC9A5 | Solute carrier family 9, subfamily A (NHE5, cation proton antiporter 5), member 5 | Predicted membrane proteins Transporters
| | | | | Tissue enhanced |
SPNS1 | Spinster homolog 1 (Drosophila) | Mitochondrial proteins Predicted membrane proteins Transporters
| | | | | Expressed in all |
STARD3 | StAR-related lipid transfer (START) domain containing 3 | Cancer-related genes Predicted membrane proteins Transporters
| | | | | Expressed in all |
STARD3NL | STARD3 N-terminal like | Predicted membrane proteins
| | | | | Expressed in all |
STEAP3 | STEAP family member 3, metalloreductase | Disease related genes Predicted membrane proteins
| | | | | Tissue enhanced |
STT3A | STT3A, subunit of the oligosaccharyltransferase complex (catalytic) | Cancer-related genes Disease related genes Enzymes Potential drug targets Predicted membrane proteins
| | | | | Expressed in all |
SUN2 | Sad1 and UNC84 domain containing 2 | Plasma proteins Predicted membrane proteins
| | | | | Expressed in all |
SYNGR1 | Synaptogyrin 1 | Predicted membrane proteins
| | | | | Expressed in all |
SYNGR3 | Synaptogyrin 3 | Predicted membrane proteins
| | | | | Group enriched |
SYNPR | Synaptoporin | Predicted membrane proteins Predicted secreted proteins
| | | | | Group enriched |
SYP | Synaptophysin | Disease related genes Potential drug targets Predicted membrane proteins Transporters
| | | | | Tissue enriched |
SYPL1 | Synaptophysin-like 1 | Predicted membrane proteins
| | | | | Expressed in all |
SYVN1 | Synovial apoptosis inhibitor 1, synoviolin | Predicted membrane proteins
| | | | | Expressed in all |